Meet The Team
George Sgouros, PhD
- B.S., Columbia University in the City of New York (New York) (1984)
- Ph.D., Cornell University (New York) (1991)
George Sgouros, PhD, is Professor of Radiology and Radiation Oncology, Director of Radiopharmaceutical Dosimetry Section of the Division of Nuclear Medicine, Johns Hopkins University, School of Medicine. He has been principal investigator or program leader on numerous grants with over twenty years experience in modeling and dosimetry of internally administered radionuclides with a particular emphasis on patient-specific dosimetry, alpha-particle dosimetry and mathematical modeling of radionuclide therapy.
Dr. Sgouros’s lab is currently engaged in pre-clinical research investigating targeted alpha-emitter therapy of metastatic cancer. He is author on more than 100 peer-reviewed articles, as well as several book chapters and review articles.
He is chairman of the Medical Internal Radionuclide Dose (MIRD) Committee as well as steering committee member, of the American Association of Physicists in Medicine (AAPM), Task Group on Internal Emitter Dosimetry and member of the National Council on Radiation Protection and Measurements (NCRP) Committee on Uncertainties in Internal Radiation Dosimetry.
He has served as chairman of the Dosimetry & Radiobiology Panel at a Department of Energy Workshop on alpha-emitters in medical therapy and, in the early 90’s, provided the physics/dosimetry support for the first FDA-approved human trial of targeted alpha-emitter therapy. He has also served on several NIH study sections and on the Oncological Sciences IRG Study Section Boundaries Team.
Eric Frey, PhD
- B.S., Davidson College (North Carolina) (1981)
- Ph.D., University of North Carolina (Chapel Hill) (North Carolina) (1989)
Dr. Eric Charles Frey is a Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science and Department of Oncology. He specializes in medical imaging physics and is a member of the Johns Hopkins Kimmel Cancer Center.
Dr. Frey received his B.S. in physics from Davidson University in 1981, and his Ph.D., also in physics, from the University of North Carolina at Chapel Hill in 1989. After a postdoctoral fellowship in radiology at the University of North Carolina at Chapel Hill, he joined the staff of the Department of Biomedical Engineering there. He joined the faculty of Johns Hopkins in 2007.
His research focuses on techniques and uses for single-photon emission computed tomography (SPECT) and positron emission tomography (PET) imaging and reconstruction to solve medical problems in cardiology, oncology and neurology. He has published more than 100 peer-reviewed research articles and several book chapters on various aspects of medical imaging and tomography. He has been awarded numerous grants in the field and has served on a variety of boards and committees.
Omid Moghadam, PhD, MBA
- B.S., State University of New York at Buffalo (New York) (1989)
- M.S., State University of New York at Buffalo (New York) (1991)
- M.B.A., University of Rochester, Simon (New York) (1997)
Omid Moghadam is an inventor and serial entrepreneur with 22 years of experience in commercializing new health technologies. He is the CEO of Ascendant Dx, a firm developing clinical tests based on newly discovered protein biomarkers. Prior to Ascendant he was at Harvard Medical School's Center for Biomedical Informatics, where he focused on applications of genomics in clinical practice. Previously, he co-founded ventures in genomics (Xovo & Intel Genomics) and electronic health records (Dossia). In the past, he has held executive positions with CGI and Kodak, where he spearheaded innovations in cardiac imaging, cryptography and digital photography. He is Chairman of the Board of Ascendant Dx, and CardioWise, and serves on the board of NanoWatt Design, Osteovantage, and Health-e Pty of Australia and advisory boards of Life Time Health Diary, and Mymee.com. He has served as an advisor to Robert Wood Johnson Foundation, California Healthcare Foundation and Children's Hospital Boston.